11betaOH-Progesterone Affects Vascular Glucocorticoid Metabolism and Contractile Response

Hypertension

Volumn 30, Issue 3, 1997, Pages 449-454

  Brem, Andrew S ^a   Bina, Robert B ^a   King, Thomas ^a   Morris, David J ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYPROGESTERONE; 11BETA HYDROXYSTEROID DEHYDROGENASE; ANGIOTENSIN; CORTICOSTERONE; DEHYDROCORTICOSTERONE; GLUCOCORTICOID; PHENYLEPHRINE; PROGESTERONE DERIVATIVE; 11 HYDROXYPROGESTERONE; 11-HYDROXYPROGESTERONE; 11-KETOPROGESTERONE; DRUG DERIVATIVE; ENZYME; PREGN 4 ENE 3,11,20 TRIONE; PROGESTERONE;

ANIMAL CELL; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; ENZYME KINETICS; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; STEROID METABOLISM; VASCULAR RING; VASCULAR SMOOTH MUSCLE; ANIMAL; DRUG EFFECT; IN VITRO STUDY; KINETICS; METABOLISM; SPRAGUE DAWLEY RAT; VASOCONSTRICTION;

ANIMALS; ENZYMES; GLUCOCORTICOIDS; HYDROXYPROGESTERONES; KINETICS; MUSCLE, SMOOTH, VASCULAR; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION;

EID: 0031225589     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.30.3.449     Document Type: Article

References (20)

1. Whitworth JA, Gordon D, Andrews J, Scoggins BA. The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume. J Hypertens. 1989;7:537-549.
2. Grunfeld JP. Glucocorticoids in blood pressure regulation. Horm Res. 1990;34:111-113. Review.
3. Kornel L, Nelson WA, Manisundaram B, Chigurupati R, Hayashi T. Mechanism of the effects of glucocorticoids and mineralocorticoids on vascular smooth muscle contractility. Steroids. 1993;58:580-587.
4. + transport in vascular smooth muscle through the glucocorticoid receptor-mediated mechanism. Am J Hypertens. 1993;6:736-744.
5. Sakaue M, Hoffman BB. Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J Clin Invest. 1991;88:385-389.
6. Guo DF, Uno S, Inagami T. Steroid hormones upregulate rat angiotensin II type 1A receptor gene: role of glucocorticoid responsive elements in rat angiotensin II type 1A promoter. J Steroid Biochem Mol Biol. 1995;53:69-73.
7. Ullian ME, Walsh LG. Corticosterone metabolism and effects on angiotensin II receptors in vascular smooth muscle. Circ Res. 1995;77:702-709.
8. Provencher PH, Saltis J, Funder JW. Glucocorticoids but not mineralocorticoids modulate endothelin-1 and angiotensin II binding in SHR vascular smooth muscle cells. J Steroid Biochem Mol Biol. 1995;52:219-225.
9. Monder C, Lakshmi V. Corticosteroid 11 beta-hydroxysteroid dehydrogenase activities in vertebrate liver. Steroids. 1988;52:515-528.
10. Edwards CRW, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, deKloet ER, Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase: tissue specific protector of the mineralocorticoid receptor. Lancet. 1988;2:986-989.
11. Naray-Fejes-Toth A, Watlington CO, Fejes-Toth G. 11beta -Hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone. Endocrinology. 1991;129:17-21.
12. Walker BR, Yau JL, Brett LP, Seckl JR, Monder C, Williams BC. 11beta-Hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology. 1991;129:3305-3312.
13. Brem AS, Bina RB, King T, Morris DJ. Bidirectional activity of 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle cells. Steroids. 1995;60:406-410.
14. Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D, Edwards CRW. Licorice inhibits corticosterone 11beta-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology. 1989;125:1046-1053.
15. Buhler H, Perschel FH, Hierholzer K. Inhibition of rat renal 11beta-hydroxysteroid dehydrogenase by steroidal compounds and triterpenoids: structure/function relationship. Biochim Biophys Acta. 1991;1075:206-212.
16. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatekeyam H, Blair IA, Hsieh FY, Takeda R. Synthesis of corticosterone in the vascular wall. Endocrinology. 1994;135:2283-2286.
17. Hatakeyama H, Miyamori I, Fujita T, Takeda R, Yamamoto H. Vascular aldosterone biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem. 1994;269:24316-24320.
18. Oertel GW, Eik-Nes K. Isolation and identification of 11Keto-progesterone, 11betaOH-progesterone, and 11betaOH-androstenedione in canine adrenal vein blood. Endocrinology. 1962;70:39-42.
19. Souness GW, Latif SA, Laurenzo JL, Morris DJ. 11alpha - and 11beta-hydroxyprogesterone, potent inhibitors of 11 beta -hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat. Endocrinology. 1995;136:1809-1812.
20. Hill NS, Klinger JR, Warburton RR, Pietras L, Wrenn DS. Brain natriuretic peptide: possible role in the modulation of hypoxic pulmonary hypertension. Am J Physiol. 1994;266(Lung Cell Mol Physiol. 10):L308-L315.